About 1 in 8 U.S. adults have taken Ozempic or similar medications used to treat Type 2 diabetes and obesity. While these ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Young adults with type 2 diabetes and lower incomes face significantly higher mortality risks, highlighting socioeconomic ...

KEY BUSINESS HIGHLIGHTSPhase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease expected to ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

But Trump can have one or the other — not both. And if his incoming administration succeeds in enacting the tariffs he’s ...

In an interview with The News-Letter, its CEO, Johns Hopkins School of Medicine Class of 1999 alum Dr. David-Alexandre C ... ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...